EXELA PHARMA FDA Approval ANDA 204797

ANDA 204797

EXELA PHARMA

FDA Drug Application

Application #204797

Application Sponsors

ANDA 204797EXELA PHARMA

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUS6GM/30ML (200MG/ML)0ACETYLCYSTEINEACETYLCYSTEINE

FDA Submissions

UNKNOWN; ORIG1AP2021-04-15STANDARD

Submissions Property Types

ORIG1Null29

TE Codes

001PrescriptionAP

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204797
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.